Patients can contribute to medication safety by questioning discrepancies, noticing unexpected changes, reporting adverse effects, checking medicines and alerting professionals to possible errors. Yet an invitation to participate can become ethically problematic when healthcare institutions begin to depend on patients to detect failures that professional and organizational safety systems should themselves prevent or identify. This article develops a normative Fair-Participation Test for distinguishing supportive patient participation from unfair transfer of medication-safety responsibility. Drawing on recent evidence concerning patient engagement, health literacy, treatment burden, responsibilisation, vulnerability, safety reporting and organizational participation, the analysis separates patient agency from institutional accountability. Five considerations are central: preservation of an adequate institutional safety baseline; genuine voluntariness; task-specific patient capacity; the incremental burden imposed by vigilance; and reciprocal institutional support and response. These considerations operate configurationally rather than as a numerical score. Unequal capacity means that identical vigilance requests can impose materially different burdens, while high capability does not by itself make institutional duties delegable. Patient participation is ethically defensible when it adds supported redundancy, preserves choice and leaves professional detection, verification and escalation responsibilities intact. It becomes burden shifting when safe care becomes practically dependent on patient vigilance, especially when nonparticipation attracts blame, avoidable risk or reduced access to appropriate response.
